Cognition Therapeutics, Inc. CGTX
0.70 USD 0.00 (+0.17%)
Nov 4, 2026, 10:54 AM EST
0.6901 Day range 0.7292
0.55 52-week range 1.83
- YTD
- -48.10%
- 1 year
- -55.37%
Financial health
Altman Z-Score
-0.93 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -4.2×
FY 2019 5y median -2.8× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 2.9×
FY 2019 5y median 2.3× FY 2025
P/FCF -4.0×
FY 2019 5y median -3.4× FY 2025
EV/EBITDA -2.7×
FY 2019 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -25.0%
FY 2019 5y median -29.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -68.5%
FY 2019 5y median -68.5% FY 2025
ROIC -136.9%
FY 2019 5y median -136.9% FY 2025
ROA -48.5%
FY 2019 5y median -48.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 11.4%
FY 2019 FY 2025
EPS (diluted) 62.4%
FY 2019 FY 2025
Free Cash Flow 13.7%
FY 2019 FY 2025
Financial Health
Current Ratio 3.4×
FY 2019 5y median 3.4× FY 2025
Quick Ratio 3.4×
FY 2019 5y median 3.4× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.6×
FY 2019 5y median 1.6× FY 2025
Interest Coverage -3677×
FY 2019 5y median -1879× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31